Similar articles

• [Pharmacokinetics of the new aminoglycoside antibiotics: tobramycin, lividomycin, amikacin, sisomicin in the patient with normal renal function and in renal insufficiency. Dosage rules].

  Oksenhendler G, Leroy A, Humbert G, Fillastre JP, Winckler C. Oksenhendler G, et al. Anesth Analg (Paris). 1977 Jan-Feb;34(1):93-110. Anesth Analg (Paris). 1977. PMID: 587022 French. No abstract available.
• Comparative pharmacokinetics of lividomycin, amikacin and sisomicin in normal subjects and in uraemic patients.

  Leroy A, Humbert G, Oksenhendler G, Fillastre JP. Leroy A, et al. J Antimicrob Chemother. 1976 Dec;2(4):373-81. doi: 10.1093/jac/2.4.373. J Antimicrob Chemother. 1976. PMID: 1052072 No abstract available.
• [Microbiology and pharmacokinetics of gentamicin, sisomicin, netilmicin and amikacin].

  Naumann P, Rosin H. Naumann P, et al. Adv Clin Pharmacol. 1978;15:23-34. Adv Clin Pharmacol. 1978. PMID: 676876 German. No abstract available.
• In vitro evaluation of ceftazidime (GR 20263), amikacin and sisomicin, in a model simulating serum pharmacokinetics of therapeutic doses.

  Xerri L, Orsolini P, Broggio R. Xerri L, et al. Chemioterapia. 1984 Oct;3(5):271-7. Chemioterapia. 1984. PMID: 6398124
• [Combined effect of cefotaxime and aminoglycoside antibiotics on Pseudomonas strains and group D streptococci].

  Linda H, Patzer J. Linda H, et al. Med Dosw Mikrobiol. 1984;36(4):223-9. Med Dosw Mikrobiol. 1984. PMID: 6100122 Polish. No abstract available.